NMI Holdings, Inc. (NMIH) Q1 2025 Earnings Call Transcript
NMI Holdings, Inc. (NASDAQ:NMIH ) Q1 2025 Earnings Conference Call April 29, 2025 5:00 PM ET Company Participants John Swenson - Vice President of Investor Relations, and Treasury Brad Shuster - Executive Chairman Adam Pollitzer - President and Chief Executive Officer Aurora Swithenbank - Chief Financial Officer Conference Call Participants Mihir Bhatia - Bank of America Bose George - KBW Rick Shane - JPMorgan Operator Good day, and welcome to the NMI Holdings, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
Here's What Key Metrics Tell Us About NMI Holdings (NMIH) Q1 Earnings
While the top- and bottom-line numbers for NMI Holdings (NMIH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
NMI Holdings (NMIH) Beats Q1 Earnings and Revenue Estimates
NMI Holdings (NMIH) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to earnings of $1.08 per share a year ago.
NMI Holdings (NMIH) Reports Next Week: Wall Street Expects Earnings Growth
NMI Holdings (NMIH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NMIH Stock Lags Industry, Trades at Discount: Time to Buy the Dip?
NMI Holdings is well-positioned for growth, with new primary insurance written, direct primary insurance in force and a better risk-based capital ratio.
NMIH Stock Trading at a Discount to Industry at 1.3X: Time to Hold?
NMI Holdings stock is poised to gain from higher new insurance written volume, a comprehensive reinsurance program, financial flexibility and prudent capital deployment.
NMI Holdings Q4 Earnings and Revenues Miss Estimates, Premiums Up Y/Y
NMIH's fourth-quarter results reflect higher premiums and net investment income but lower persistency.
NMI Holdings, Inc. (NMIH) Q4 2024 Earnings Call Transcript
NMI Holdings, Inc. (NASDAQ:NMIH ) Q4 2024 Earnings Conference Call February 6, 2025 5:00 PM ET Company Participants John Swenson - Vice President of Investor Relations, and Treasury Brad Shuster - Executive Chairman Adam Pollitzer - President and Chief Executive Officer Aurora Swithenbank - Chief Financial Officer Conference Call Participants Doug Harter - UBS Terry Ma - Barclays Capital Bose George - KBW Rick Shane - J.P. Morgan Mark Hughes - Truist Securities Mihir Bhatia - Bank of America Operator Good day, and welcome to the NMI Holdings, Inc. Fourth Quarter 2024 Earnings Conference Call.
NMI Holdings (NMIH) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for NMI Holdings (NMIH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
NMI Holdings (NMIH) Lags Q4 Earnings and Revenue Estimates
NMI Holdings (NMIH) came out with quarterly earnings of $1.07 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.01 per share a year ago.
NMI Holdings Stock Trades Above 50-Day SMA: What Should Investors Do?
NMIH stock is poised to gain from higher new insurance written volume, a comprehensive reinsurance program, financial flexibility and prudent capital deployment.
Undercovered Dozen: Lincoln National, Whitecap Resources, NMI Holdings, Healwell AI +
The 'Undercovered' Dozen series highlights lesser-covered stocks, providing investment ideas and encouraging discussions on their potential. Arcus Biosciences is seen as a "Strong Buy" due to its promising oncology combo therapies and partnerships with Gilead and AstraZeneca. Edmund Ingham sees Sarepta Therapeutics, despite past valuation concerns, as a "Buy" with potential for >50% gain by YE25, driven by Elevidys and ongoing clinical programs.
